综述:瞬时受体电位通道作为肠易激综合征可能治疗靶点
本文综述了瞬时受体电位(TRP)通道在内脏痛觉中的作用及肠易激综合征(IBS)治疗启示。通过PubMed检索相关文献,发现TRPV1、TRPV4、TRPA1参与内脏痛信号生成,TRPM8参与抑制,内源性TRP激动剂如多不饱和脂肪酸代谢物和硫化氢与IBS内脏痛增强相关,新靶点TRPA1和TRPV4及替代调控方式正在探索。
要点
- TRPV1、TRPV4、TRPA1参与内脏痛信号生成,TRPM8参与抑制。
- 内源性TRP激动剂如多不饱和脂肪酸代谢物和硫化氢与IBS内脏痛增强相关。
- 新治疗靶点TRPA1和TRPV4及部分拮抗剂、下游靶向和RNA疗法正在探索。
核心结论
- 对内脏痛觉机制的理解改善为IBS腹痛新治疗策略开发提供了坚实基础。
研究设计与样本
- 通过PubMed电子数据库检索文献,检索词为「内脏痛觉」「内脏高敏感」「肠易激综合征」和「瞬时受体电位通道」,筛选摘要后对相关文章交叉引用以获取额外文献。
主要发现
- TRPV1、TRPV4、TRPA1参与内脏痛信号生成,TRPM8参与抑制。
- 内源性TRP激动剂包括多不饱和脂肪酸代谢物和硫化氢,与IBS内脏痛增强相关。
- 新治疗靶点TRPA1和TRPV4已被识别,部分拮抗剂、下游靶向和RNA-based疗法等替代调控TRP通道信号的方式正在探索。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abdominal pain in irritable bowel syndrome (IBS) remains challenging to treat effectively. Researchers have attempted to elucidate visceral nociceptive processes in order to guide treatment development. Transient receptor potential (TRP) channels have been implied in the generation (TRPV1, TRPV4, TRPA1) and inhibition (TRPM8) of visceral pain signals. Pathological changes in their functioning have been demonstrated in inflammatory conditions, and appear to be present in IBS as well. AIM: To provide a comprehensive review of the current literature on TRP channels involved in visceral nociception. In particular, we emphasise the clinical implications of these nociceptors in the treatment of IBS. METHODS: Evidence to support this review was obtained from an electronic database search via PubMed using the search terms "visceral nociception," "visceral hypersensitivity," "irritable bowel syndrome" and "transient receptor potential channels." After screening the abstracts the articles deemed relevant were cross-referenced for additional manuscripts. RESULTS: Recent studies have resulted in significant advances in our understanding of TRP channel mediated visceral nociception. The diversity of TRP channel sensitization pathways is increasingly recognised. Endogenous TRP agonists, including poly-unsaturated fatty acid metabolites and hydrogen sulphide, have been implied in augmented visceral pain generation in IBS. New potential targets for treatment development have been identified (TRPA1 and TRPV4,) and alternative means of affecting TRP channel signalling (partial antagonists, downstream targeting and RNA-based therapy) are currently being explored. CONCLUSIONS: The improved understanding of mechanisms involved in visceral nociception provides a solid basis for the development of new treatment strategies for abdominal pain in IBS.
引用
- Beckers AB, Weerts ZZRM, Helyes Z, et al. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome. Aliment Pharmacol Ther. 2017. PMID: 28884838. doi:10.1111/apt.14294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。